Influenza News and Research

Latest Influenza News and Research

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Green tea, chokeberry juice, and pomegranate juice killed flu and SARS-CoV-2 viruses when incubated with the viruses in vitro. Thus, oral rinsing using these might be effective in preventing COVID-19.

5 Nov 2020

Case study reports prolonged infectious SARS-CoV-2 shedding from an asymptomatic leukemia patient

The majority of people infected with SARS-CoV-2 appear to actively shed infectious virus for about 8 days, but there is a wide range of variability from person to person.

4 Nov 2020

Zinc-embedded polyamide fabrics are effective in absorbing and inactivating SARS-CoV-2

An international team of scientists has recently demonstrated that zinc-embedded polyamine fibers can effectively absorb and inactivate human respiratory viruses, including influenza A virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Thus, a face mask or other personal protective equipment (PPE) made from this fiber is expected to provide better protection against viral transmission.

4 Nov 2020

Correlations found between 'long-COVID' patients and preexisting health conditions

Researchers from the nference (a biotech information firm) in Cambridge, MA, USA, the Mayo Clinic in Rochester, MN, USA, and nference Labs based in Bengaluru, India, recently performed a retrospective analysis of 266 COVID-19 patients.

4 Nov 2020

Adaptive evolution of human coronaviruses may necessitate frequent reformulation of vaccines

Researchers from the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center, USA, have revealed that adaptive evolution in the antigenic regions facilitates seasonal coronaviruses to escape the host immune responses and to cause recurrent infections.

3 Nov 2020

New model uses people’s breathing rates to track virus-carrying droplets

How many virus particles you inhale and where they land within the respiratory tract can affect your chances of contracting COVID-19, according to assistant professor Saikat Basu of South Dakota State University's Department of Mechanical Engineering.

3 Nov 2020

Only 56 percent of people intend to have free flu vaccination in the U.K. amid COVID

Now, a team of researchers at Keele University and Public Health England aimed to determine how many residents in the U.K. intend to get flu shots amid the COVID-19 pandemic. The researchers found that 55.8 percent of people intended to have the vaccination.

2 Nov 2020

New AI-powered forecasting tool makes prediction of flu outbreaks easier

Predicting influenza outbreaks just got a little easier, thanks to a new A.I.-powered forecasting tool developed by researchers at Stevens Institute of Technology.

2 Nov 2020

The Sun plays a role in the evolution of viral respiratory epidemics

Why do most viral epidemics spread cyclically in autumn and winter in the globe's temperate regions? According to an interdisciplinary team of researchers of the Italian National Institute for Astrophysics, the University of Milan, the Lombardy regional agency for the environment and the Don Gnocchi Foundation, the answer is intimately related to our Sun: their theoretical model shows that both the prevalence and evolution of epidemics are strongly correlated with the amount of daily solar irradiation that hits a given location on the Earth at a given time of the year.

2 Nov 2020

New project aims to find the effect of COVID-19 infection on the next generation

So far, 50 Covid-19 patients between 30 and 40 have delivered a sperm sample. Students are next in line. The plan is that participants will return after 12 months for more testing.

2 Nov 2020

Researchers identify new drug candidate with potential to treat COVID-19

Researchers from the University of Kent, the Goethe-University in Frankfurt am Main (Germany), and the Hannover Medical School (Germany) have identified a drug with the potential to provide a treatment for COVID-19.

30 Oct 2020

Experts call for transformative change to reduce future pandemics

Future pandemics will emerge more often, spread more rapidly, do more damage to the world economy and kill more people than COVID-19 unless there is a transformative change in the global approach to dealing with infectious diseases, warns a major new report on biodiversity and pandemics by 22 leading experts from around the world.

30 Oct 2020

Study: ICE detention centers experienced repeated outbreaks of vaccine-preventable illnesses

More than a dozen U.S. Immigration and Customs Enforcement (ICE) detention centers experienced large, repeated outbreaks of vaccine-preventable illnesses in the last three years, according to a new study by researchers at UC San Francisco.

30 Oct 2020

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

Fifteen hundred frontline workers are being recruited for a yearlong study to find what percentage are positive for the virus that causes COVID-19, what percentage become positive and whether the antibodies they produce protect them from reinfection.

30 Oct 2020

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

A recent study published on the preprint server medRxiv* in October 2020 shows the need for large-scale studies on the clinical characteristics and outcomes of COVID-19 at the national and international scale. This is essential to shape interventions and optimize the use of resources to contain and manage a second wave of the pandemic.

30 Oct 2020

COVID-19 patients at risk of fatal co-infection during ICU stays

Researchers in the UK have conducted a study showing that a high proportion of patients admitted to intensive care units (ICU) with coronavirus disease 2019 (COVID-19) acquire a secondary bacterial co-infection during their hospital stay.

29 Oct 2020

Mental health challenges associated with COVID-19 lockdown in spring 2020

This brief is a summary of the policy brief prepared in the context of the Swiss national COVID-19 science task force (https://ncs-tf.ch/en/).

29 Oct 2020

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

By exploiting type 1 interferon's ability to foster an antagonistic cellular environment for viral replication, a research group from France pinpointed DEAD-box RNA helicase DDX42 as an intrinsic inhibitor of HIV, but also other pathogenic viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Chikungunya virus.

29 Oct 2020

Research shows why certain people infected with COVID-19 show no symptoms

Researchers worldwide have been surprised to see that individuals can be infected with the SARS-CoV-2 virus - the virus that produces COVID-19 - without showing symptoms. Since these individuals expose others to infection without knowing it, it is important to find an explanation and hopefully a solution to this.

29 Oct 2020

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

29 Oct 2020

Influenza News and Research

Latest Influenza News and Research

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Case study reports prolonged infectious SARS-CoV-2 shedding from an asymptomatic leukemia patient

Zinc-embedded polyamide fabrics are effective in absorbing and inactivating SARS-CoV-2

Correlations found between 'long-COVID' patients and preexisting health conditions

Adaptive evolution of human coronaviruses may necessitate frequent reformulation of vaccines

New model uses people’s breathing rates to track virus-carrying droplets

Only 56 percent of people intend to have free flu vaccination in the U.K. amid COVID

New AI-powered forecasting tool makes prediction of flu outbreaks easier

The Sun plays a role in the evolution of viral respiratory epidemics

New project aims to find the effect of COVID-19 infection on the next generation

Researchers identify new drug candidate with potential to treat COVID-19

Experts call for transformative change to reduce future pandemics

Study: ICE detention centers experienced repeated outbreaks of vaccine-preventable illnesses

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

COVID-19 patients at risk of fatal co-infection during ICU stays

Mental health challenges associated with COVID-19 lockdown in spring 2020

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Research shows why certain people infected with COVID-19 show no symptoms

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Influenza News and Research

Latest Influenza News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in